Compare drug alternatives
Qulipta® Alternatives
Qulipta®
(Atogepant)
Qulipta
-
Migraine
- Emgality®
- Vyepti®
- Ajovy®
- Nurtec ODT®
- Ubrelvy®
Prescription Only
Qulipta is a prescription medication that is used as a preventative treatment for episodic migraines. It is a tablet that is taken once daily. The most common side effects are fatigue, nausea, and constipation.
Qulipta is FDA approved for the following indications: Migraine prevention.
Aimovig®
(Erenumab)
Aimovig
-
Migraine
- Emgality®
- Vyepti®
- Ajovy®
- Nurtec ODT®
- Ubrelvy®
Prescription Only
Aimovig is a prescription medication that adults can self-inject once a month under the skin to prevent migraine headaches. The most common side effects are injection site reactions and constipation. However, there are no reported instances of drug interactions with Aimovig.
Aimovig is FDA approved for the following indications: Migraine prevention.
Dosage & Administration
Administration
Oral
Subcutaneous
Dosing
10 mg, 30 mg, or 60 mg once daily. Severe Renal Impairment or End-Stage Renal Disease: 10 mg once daily.
70 mg once monthly or 140 mg once monthly (for some patients)
Latin Shorthand
10mg qd, 30mg qd or 60mg qd
Renal Impairment: 10mg qd
70 mg/mo or 140 mg/mo
Financial Assistance
Copay
$0
$5
Annual Cap
$6,000
Patient specific maximum benefit.
Assistance Expiration
12 30-day prescription fills
Calendar year
Generics
No lower-cost generic available
No lower-cost generic available